US8779151B2

Orally bioavailable caffeic acid related anticancer drugs

University of Texas System

Abstract

The present invention concerns compounds and their use to treat cell proliferative diseases such as cancer. Compounds of the present invention display significant potency as inhibitors of Jak2/STAT3 pathways and downstream targets and inhibit the growth and survival of cancerous cell lines.

University: University of Texas System
Assignee: The Board Of Regents Of The University Of Texas System
Inventor: Waldemar Priebe
Priority date: March 31, 2006
Filing date: April 02, 2007
Grant date: July 15, 2014
Publication date: July 15, 2014
Language: en
PDF source: https://patentimages.storage.googleapis.com/ee/b6/5c/92eef6458b84f6/US8779151.pdf
Metadata fetched: August 29, 2026 00:21